Performance in Delivering Clinical Research Lancashire Care NHS Foundation Trust Q2 2016-17 – – Total Target Number Number Target Number Date Research Integrated Of Of Date To Of Date That Total Agreed to Reason Ethics Research Of Patients Patients Recruit Patients The Trial Number Of Name of recruit For Id Committee Agreed Closed To Study Comments Trial target Closure Of Reference System (Enter (Enter At The number of Trial Number Number Agreed Same In Same In Agreed Recruited patients Both If Both If Target Only One Only One Date Number) Number) LUPIN: A Randomized, Double-blind, controlled, Parallel Group, Comparative, Sponsor Multicentre, closed Phase 2 due to Clinical Study Number Date 167986 3 3 05/05/2016 0 By 1 to Evaluate Agreed Agreed 6 Sponsor Efficacy and Safety of Two Doses of LND101001 in Patients with Mild to Moderate Alzheimer’s Disease STARBEAM: Randomised, double blind, parallel group, placebo Sponsor closed fixed dose due to study of Lu Number Date 14/SS/1018 149117 6 6 25/05/2016 0 By AE58054 in Agreed Agreed Sponsor patients with Alzheimer’s disease treated with donepezil; Study 2
Performance in Delivering Clinical Research – Lancashire Care NHS Foundation Trust – Q2 2016-17 Id Research Ethics Committee Reference Number Integrated Research System Number Name of Trial Target Of Number Of Patients Agreed (Enter Same In Both If Only One Number) Number Of Patients Agreed (Enter Same In Both If Only One Number) Target Date To Recruit Date Agreed to recruit target number of patients Total Number Of Patients At The Agreed Target Date Date That The Trial Closed To Total Number Of Study Recruited Reason For Closure Of Trial Comments 167986 LUPIN: A Randomized, Double-blind, Parallel Group, Comparative, Multicentre, Phase 2 Clinical Study to Evaluate Efficacy and Safety of Two Doses of LND101001 in Patients with Mild to Moderate Alzheimer’s Disease Number Agreed 1 3 Date Agreed 3 05/05/2016 0 By Sponsor Sponsor closed due to 14/SS/1018 149117 STARBEAM: Randomised, double blind, parallel group, placebo controlled, fixed dose study of Lu AE58054 in patients with Alzheimer’s disease treated with donepezil; Study 2 Number Agreed 6 6 Date Agreed 6 25/05/2016 0 By Sponsor Sponsor closed due to